Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm
Yoonjung Choi(Deargen (South Korea)), Yoon Ho Ko(St. Mary's Hospital)
Cited by 2
Related Papers
QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth
|International Journal of Cancer|2019|75
Prevalence and risk factors of periodontitis among adults with or without diabetes mellitus
|The Korean Journal of Internal Medicine|2016|49